Marrone Bio Innovations Inc (NASDAQ:MBII) CEO Pam Marrone tells Proactive the bioprotection and plant health company posted third-quarter results that saw revenue jump 28% year-over-year on the back of the company’s specialty crop and cultivated garden businesses.
Marrone says revenue was $7 million for Q3, up from $5.4 million a year earlier, beating Street estimates of $6.95 million.
Price: 1.23 USD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
Marrone Bio Innovations (NASDAQ: MBII) CEO and Founder Dr Pam Marrone joined Steve Darling from Proactive Vancouver on Skype with news that two of its biofungicide products Stargus and Regalia have been approved by the U.S. Environmental Protection Agency for indoor and outdoor use on hemp...
Industry & services
Industry & services
